Table 3 Neisseria gonorrhoea infections and prostate cancer
Study | Country | Method for gonorrhoea | Prostate cancer | Prostate non cancer controls | P value |
|---|---|---|---|---|---|
Heshmat 1975 [69] | US | Self report | 35/75 47% | 29/75 39% | 0.486 ns |
Baker 1981 [70] | US | Self report | 20/44 45% | 14/90 16% | 0.005 s |
Lees 1985 [71] | Canada | Clinical records | 13/83 16% | 30/166 18% | 0.689 ns |
Mishina 1985 [72] | Japan | Self report | 26/100 26% | 21/100 21% | 0.512 ns |
Checkoway 1987 [73] | US | Self report | 6/40 15% | 8/64 13% | 0.752 ns |
Honda 1988 [74] | US | Self report | 33/216 15% | 25/216 12% | 0.324 ns |
Oishi 1989 [75] | Japan | Self report | 9/100 9% | 35/200 18% | 0.086 ns |
La Vecchia 1993 [76] | Italy | Self report | 3/271 1% | 14/685 2% | 0.837 ns |
Hiatt 1994 [77] | US | Medical record | 9/238 4% | 6/238 3% | 0.446 ns |
Ilic 1996 [78] | Serbia | Self report | 4/101 4% | 0/202 0% | 0.016 s |
Hsieh 1999 [79] | Greece | Self report | 39/320 12% | 22/246 9% | 0.267 ns |
Hayes 2000 [80] | US Blacks US Whites | Self report Self report | 115/477 24% 15/501 3% | 103/588 18% 18/711 3% | 0.032 s 0.623 ns |
Rosenblatt 2001 [81] | US | Self report | 85/753 11% | 67/703 10% | 0.623 ns |
Sanderson 2004 [82] | US | Self report | 43/401 11% | 33/389 8% | 0.332 ns |
Patel 2005 [83] | US blacks US whites | Self report | 139/353 40% 16/347 5% | 94/257 37% 18/347 5% | 0.449 ns 0.738 ns |
Pelucci 2006 [84] | Italy | Self report | 4/280 1% | 17/689 3% | 0.611 ns |
Sarma 2006 [85] | US blacks | Self report | 84/129 66% | 369/703 53% | 0.001 s |
Sutcliffe 2006 [86] | US | Self report | 55/8770 1% | 1999/291,519 1% | 0.853 ns |
Huang 2008 [87] | US blacks US whites | Self report | 30/98 31% 30/762 4% | 115/353 33% 26/907 3% | 0.753 ns 0.832 ns |
Hrbacek 2011 [88] | Czech Republic | Serology | 20/328 6% | 6/105 6% | 0.917 ns |
Vazquez-Salas 2015 [89] | Mexico | Self report | 81/402 20% | 46/805 6% | 0.001 s |
Wang 2017 [90] | Taiwan | Laboratory | 6/355 2% | 5/1420 0.4% | 0.001 s |